News

Check out market updates

MiRagen reports loss, effects reverse stock split

BOULDER — miRagen Therapeutics Inc. (Nasdaq: MGEN), a Boulder-based biotechnology company developing new treatments for patients with diseases that are […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X